Filter
611
Text search:
PrEP
Featured
Recommendations
65
New Publications
123
Language
Document type
No document type
265
Guidelines
140
Studies & Reports
111
Strategic & Response Plan
25
Fact sheets
25
Manuals
14
Infographics
12
Brochures
8
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
South Africa
21
Global
20
Kenya
14
Zambia
12
Asia
12
Namibia
10
Uganda
9
Malawi
7
Africa
7
Nepal
6
Latin America and the Carribbean
6
Eastern Europe
6
Nigeria
5
Senegal
5
Congo, Democratic Republic of
5
Ethiopia
5
India
5
Myanmar / Burma
5
Russia
5
Ghana
4
Philippines
4
Germany
4
Argentina
4
Brazil
4
Lesotho
4
Western and Central Europe
4
Sierra Leone
3
Syria
3
Ukraine
3
East and Southern Africa
3
South–East Asia Region
3
Georgia
3
Liberia
2
Haiti
2
Botswana
2
Yemen
2
Middle East and North Africa
2
Guinea-Bissau
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Tanzania
1
Cambodia
1
Rwanda
1
Mozambique
1
Sudan
1
Central African Republic
1
Eswatini/ Swaziland
1
Honduras
1
El Salvador
1
Angola
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Bhutan
1
Armenia
1
Authors & Publishers
Publication Years
Category
Countries
145
Clinical Guidelines
46
Women & Child Health
23
Public Health
7
Key Resources
7
Pharmacy & Technologies
5
Capacity Building
1
Toolboxes
HIV
353
COVID-19
24
Refugee
13
Caregiver
11
NTDs
10
Health Financing Toolbox
9
Rapid Response
8
TB
8
Mental Health
7
Planetary Health
7
Polio
5
Specific Hazards
4
Cholera
3
Natural Hazards
3
Disability
2
Ebola & Marburg
2
Zika
2
AMR
2
2.0 Rapid Response
2
Conflict
1
Global Health Education
1
Pharmacy
1
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
what lessons can we take from the last few decades of health behaviour change efforts as we enter the era of HIV prevention pills, rings and injections?
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex C
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex D
This brief from Audere and AVAC explains how artificial intelligence (AI) can support the HIV field by expanding reach, enhancing prevention, and improving care.
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that
...
This technical brief aims to support these trends, accelerated by the COVID-19 pandemic, and improve PrEP uptake, persistence, and effective use by providing implementation guidance for differentiated and simplified service delivery. The brief aims
...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people at substantial risk of HIV infection. CAB-LA is an injectable form of pre-exposure prophylaxis (PrEP
...